>Marché des logiciels de dépistage du cancer du poumon au Moyen-Orient et en Afrique, par mode de livraison (solutions basées sur le cloud, solutions sur site et solutions basées sur le Web), produit (solution de radiologie de dépistage du cancer du poumon, logiciel de gestion des patients pour le dépistage du cancer du poumon, logiciel de gestion des nodules, collecte et création de rapports de données, coordination et flux de travail des patients, détection assistée par ordinateur des nodules pulmonaires, pathologie et stadification du cancer, rapports d'audit statistique, PAC de dépistage, gestion de la pratique et suivi des journaux d'audit), type (dépistage assisté par ordinateur et dépistage traditionnel), application ( cancer du poumon non à petites cellules (NSCLC) et cancer du poumon à petites cellules (SCLC)), plate-forme (autonome et intégrée), mode d'achat (institutionnel et individuel), utilisateur final (centres d'oncologie, hôpitaux, centres de chirurgie ambulatoire et autres), canal de distribution (appel d'offres direct et distributeurs tiers) - Tendances et prévisions de l'industrie jusqu'en 2029.
Analyse et taille du marché des logiciels de dépistage du cancer du poumon au Moyen-Orient et en Afrique
Le contrôle des taux de mortalité par cancer du poumon est l'une des principales préoccupations des établissements de santé. Les organismes publics et privés prennent des initiatives pour lancer des programmes de dépistage afin de contrôler les taux de mortalité. En outre, les entreprises lancent des logiciels avancés pour faciliter la gestion des données des patients et fournir de meilleurs soins avec des directives strictes en matière de confidentialité des données.
L'augmentation de la prévalence du cancer du poumon, la sensibilisation croissante de la population au cancer du poumon, l'augmentation des initiatives gouvernementales et le nombre croissant de programmes de dépistage sont quelques-uns des principaux facteurs à l'origine de la croissance du marché. En outre, les progrès des solutions basées sur l'intelligence artificielle (IA) et les initiatives stratégiques des principaux acteurs du marché créent des opportunités dans le domaine des logiciels de dépistage du cancer du poumon.
Cependant, les problèmes de confidentialité des données et le manque de main-d’œuvre non qualifiée devraient entraver la croissance du marché au cours de la période de prévision.
Data Bridge Market Research analyse que le marché des logiciels de dépistage du cancer du poumon au Moyen-Orient et en Afrique devrait atteindre la valeur de 835,45 milliers de dollars d'ici 2029, à un TCAC de 14,9 % au cours de la période de prévision. Les solutions basées sur le cloud représentent le segment de mode de livraison le plus important du marché. Le rapport de marché couvre également en profondeur l'analyse des prix, l'analyse des brevets et les avancées technologiques.
|
Rapport métrique |
Détails |
|
Période de prévision |
2022 à 2029 |
|
Année de base |
2021 |
|
Années historiques |
2020 (personnalisable pour 2019-2014) |
|
Unités quantitatives |
Chiffre d'affaires en milliers de dollars américains, prix en dollars américains |
|
Segments couverts |
By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions and Web Based Solutions), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking), Type (Computer-Assisted Screening and Traditional Screening), Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), Platform (Standalone and Integrated), Purchase Mode (Institutional and Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender and Third Party Distributors) |
|
Countries Covered |
U.A.E., Saudi Arabia, Israel, Egypt, South Africa, and rest of Middle East and Africa |
|
Market Players Covered |
PenRad Technologies Inc., Koninklijke Philips N.V, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmbH, MyCareWare, Inc., MagView, MeVis Medical Solutions AG, Canon Medical Informatics, Inc., General Electric Company, Epic Systems Corporation, Lungview, Eon, Medtronic, Coreline Soft Co., Ltd., Optellum Ltd, HealthMyne, Oncocyte Corporation, Genesystem, REVEALDX, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd, Median Technologies, AstraZeneca, and Aidence.com |
Market Definition
Lung cancer screening is identifying stages of lung cancer using different technologies and software. Lung cancer screening using CT is the most recommended technique for screening lung cancer. The rising use of this technique is expected to accelerate the need for advanced software for lung cancer screening. This software helps to manage patients’ participation in lung screening programs and provides an efficient way for healthcare professionals to collect, curate, and transfer data to clinicians and patients. In addition, this software enables in the identification of patients at risk and automates the flow of data with integrated electronic health records.
Middle East and Africa Lung Cancer Screening Software Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Increase in prevalence of lung cancer cases globally
Lung cancer is a leading cause of death in men and women. According to World Cancer Research Fund International, lung cancer is the second most common cancer worldwide. It is the most common cancer in men and second most common in women. There were more than 2.2 thousand new cases of lung cancer in 2020. Increasing prevalence of lung cancer cases creates need to adopt lung cancer screening software for early diagnosis and acts as a driving factor for the market growth.
- Increase in awareness regarding the benefits of early diagnosis and frequent screening
The rising awareness programs of lung cancer by public, non-profit, and private organizations are anticipated to boost the market growth. These initiatives aim to prevent diseases, reduce stigma and prejudice, and promote research. The awareness among the population regarding lung cancer has increased. Because there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed early. Thus, raising awareness among populations is driving market growth.
- Government initiatives were undertaken to implement screening programs for various diseases
The burden of cancer continues to increase globally and has great financial, emotional, and physical stress on health systems, products, families, and individuals. In countries with strong health systems, the survival rate of many types of cancer is improved due to survivorship, quality care, increased awareness, and accessible early detection. Centers for Disease Control and Prevention, U.S., tribes, and the U.S.-Pacific islands and territories through the National Comprehensive Cancer Control Program (NCCCP) are to form or support alliances to combat cancer in their communities. Due to these initiatives, more audiences are educated and more consciously dispersed, pushing the global audience to take further precautions and practice preventive examinations, promoting the market.
- Growing number of screening programs across the globe
Screening is an effective method of detecting early-stage cancer. There is an increasing trend in lung cancer incidences in developing countries. Although there are regular recommendations for screening for breast and cervical cancer, it is not the same in case of lung cancer. Most countries or institutions have initiated the feasibility and disease screening of Low-Dose Computed Tomography (LDCT) for lung cancer. The increasing number of lung cancer screening has created an opportunity for the market players. Hence, the increasing diagnostic rate acts as a driving factor for market growth.
Opportunity
-
Rising collaborations, mergers & acquisitions among the market players
The companies operating in the market are adopting several strategies, including mergers and acquisitions, product launches, agreements, pipeline development, collaborations, and market expansion among others, to boost their business in various dimensions. These strategic decisions by the companies are expected to offer significant opportunities for the market players operating in the market.
Restraints/Challenges
- Issues related to the availability of software
There are certain issues/barriers related to effective and efficient lung cancer screening and the availability of lung cancer screening software in developing nations. Issues are competing demands for time, knowledge about lung cancer screening, evolving attitudes about the effectiveness of screening, nihilism related to historically poor lung cancer treatment outcomes, and limited training and requirement approval for local authorities or country medical device regulatory body. All these issues delay launches and availability of the product. Also, the demand for lung cancer screening software is hampered due to technical issues related to the available software thereby, acting as a restraint for market growth.
Post-COVID-19 Impact on Middle East and Africa Lung Cancer Screening Software Market
COVID-19 created a major impact on various industries as almost every country opted for the shutdown of every facility except the ones dealing in the essential goods segment. The government took some strict actions such as the shutdown of facilities and sale of non-essential goods, blocking international trade, and many more to prevent the spread of COVID-19. The only business which was running during this pandemic situation was the essential services that were allowed to open and run the processes.
COVID-19 created new and unfamiliar challenges for healthcare providers to deliver patient care. Many non-essential but important services such as lung cancer screening were temporarily suspended to protect the health of staff and patients. Healthcare institutions faced unprecedented challenges regarding scheduling, patient monitoring, and follow-up of patient-service communication to ensure continuity of care during COVID-19 and when services could be continued safely. COVID-19 created new challenges for lung cancer screening programs, in many cases, delaying screening by several months and creating more difficulties for management and scheduling teams. Although the COVID-19 crisis shed new light on the importance of respiratory assistance, it will hopefully have a major impact on reducing stigma of screening for cancer. There are more than 10,000,000 eligible patients in the U.S. who are eligible for lung cancer screening, less than 5 percent of whom are actively enrolled in the screening program. COVID-19 created a negative impact on the market.
However, the lung cancer screening software companies are struggling and continuously taking different strategic decisions to control the situation. The players are involved in strategic activities such as partnerships, collaborations, and mergers & acquisitions among others to improve the technology involved in the market. With this, the companies will bring advanced and accurate solutions to the market. In addition, the government initiatives to boost digitization across industries have also led to market growth.
Recent Developments
- In July 2022, GE Healthcare launched their latest product and most advanced ultrasound, the next-generation Voluson Expert 22. This latest addition to GE Healthcare’s award-winning Women’s Health portfolio utilizes graphic-based beam former technology, which produces higher quality images and offers greater flexibility in imaging functions. With this product, the company made its position much stronger in the area of products and service providers to healthcare institutions.
- In October 2021, Thynk Health announced a partnership with Infervision, to fight lung cancer with the world’s most advanced technologies. It offers an opportunity for lung cancer screening and pulmonary nodule management. With this partnership, the company increased its market presence.
Middle East and Africa Lung Cancer Screening Software Market Scope
Middle East and Africa lung cancer screening software market is segmented into eight notable segments based on mode of delivery, product, type, application, platform, purchase mode, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Mode of Delivery
- Cloud Based Solutions
- On-Premise Solutions
- Web Based Solutions
On the basis of mode of delivery, the market is segmented into cloud based solutions, on premise solutions, and web based solutions.
Product
- Lung Cancer Screening Radiology Solution
- Lung Cancer Screening Patient Management Software
- Nodule Management Software
- Data Collection and Reporting
- Patient Coordination and Workflow
- Lung Nodule Computer Aided Detection
- Pathology and Cancer Staging
- Statistical Audit Reporting
- Screening PACS
- Practice Management
- Audit Log Tracking
On the basis of product, the market is segmented into lung cancer screening radiology solution, lung cancer screening patient management software, nodule management software, data collection and reporting, patient coordination and workflow, lung nodule computer aided detection, pathology and cancer staging, statistical audit reporting, screening PACS, practice management, and audit log tracking.
Type
- Computer-Assisted Screening
- Traditional Screening
On the basis of type, the market is segmented into computer-assisted screening and traditional screening.
Application
On the basis of application, the market is segmented into Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).
Platform
- Standalone
- Integrated
On the basis of platform, the market is segmented into standalone and integrated.
Purchase Mode
- Institutional
- Individual
On the basis of purchase mode, the market is segmented into individual and institutional.
End User
- Oncology Centers
- Hospitals
- Ambulatory Surgical Centers
- Others
On the basis of end user, the market is segmented into hospitals, oncology centers, ambulatory surgical centers, and others.
Distribution Channel
- Direct Tender
- Third Party Distributors
On the basis of distribution channel, the market is segmented into direct tender and third party distributors.
Middle East and Africa Lung Cancer Screening Software Market Regional Analysis/Insights
Middle East and Africa market is analyzed and market size insights and trends are provided based on mode of delivery, product, type, application, platform, purchase mode, end user, and distribution channel as referenced above.
The countries covered in this market report are U.A.E., Saudi Arabia, Israel, Egypt, South Africa, and rest of Middle East and Africa. Saudi Arabia dominates the market owing to factors such as, on-going strategic partnerships and the presence of major key players in the region. Moreover, some underdeveloped countries in this region do not have access to technological services in the healthcare sector which has led to the region slow growth in the market.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Middle East and Africa Lung Cancer Screening Software Market Share Analysis
Middle East and Africa lung cancer screening software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are PenRad Technologies Inc., Koninklijke Philips N.V, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmBH, MyCareWare, Inc., MagView, MeVis Medical Solutions AG, Canon Medical Informatics, Inc., General Electric Company, Epic Systems Corporation, Lungview, Eon, Medtronic, Coreline Soft, Co., Ltd., Optellum Ltd, HealthMyne, Oncocyte Corporation, Genesystem, REVEALDX, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd, Median Technologies, AstraZeneca, and Aidence.com among others.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATIONS & REIMBURSEMENT
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASE IN PREVALENCE OF LUNG CANCER CASES MIDDLE EAST & AFRICALY
6.1.2 INCREASE IN AWARENESS REGARDING THE BENEFITS OF EARLY DIAGNOSIS AND FREQUENT SCREENING
6.1.3 GOVERNMENT INITIATIVES WERE UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
6.1.4 GROWING NUMBER OF SCREENING PROGRAMS ACROSS THE GLOBE
6.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE
6.2 RESTRAINTS
6.2.1 ISSUES RELATED TO THE AVAILABILITY OF SOFTWARE
6.2.2 SCARCITY OF TECHNICALLY KNOWLEDGEABLE PROFESSIONALS FOR CANCER DIAGNOSIS
6.2.3 LACK OF FUNDING AND OTHER RESOURCES FROM VARIOUS REGIONS FOR CANCER AND ASSOCIATED DISORDERS
6.3 OPPORTUNITIES
6.3.1 RISING COLLABORATIONS, MERGERS & ACQUISITIONS AMONG THE MARKET PLAYERS
6.3.2 INCREASING INVESTMENTS IN HEALTHCARE SEGMENTS
6.3.3 MULTIPLE BENEFITS ASSOCIATED WITH LUNG CANCER SCREENING SOFTWARE
6.4 CHALLENGES
6.4.1 HIGH COST OF SCREENING SOFTWARE AND RELATED SERVICES
6.4.2 INCREASING CHALLENGES RELATED TO THE DEVELOPMENT OF LUNG CANCER SCREENING SOFTWARE
6.4.3 INCREASING COMPETITION IN THE MARKET
7 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY
7.1 OVERVIEW
7.2 CLOUD BASED SOLUTIONS
7.3 ON-PREMISE SOLUTIONS
7.4 WEB BASED SOLUTIONS
8 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 LUNG CANCER SCREENING RADIOLOGY SOLUTION
8.2.1 ON-PREMISE SOLUTIONS
8.2.2 WEB BASED SOLUTIONS
8.2.3 CLOUD BASED SOLUTIONS
8.3 LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE
8.3.1 CLOUD BASED SOLUTIONS
8.3.2 ON-PREMISE SOLUTIONS
8.3.3 WEB BASED SOLUTIONS
8.4 NODULE MANAGEMENT SOFTWARE
8.4.1 CLOUD BASED SOLUTIONS
8.4.2 ON-PREMISE SOLUTIONS
8.4.3 WEB BASED SOLUTIONS
8.5 DATA COLLECTION AND REPORTING
8.5.1 CLOUD BASED SOLUTIONS
8.5.2 WEB BASED SOLUTIONS
8.5.3 ON-PREMISE SOLUTIONS
8.6 PATIENT COORDINATION AND WORKFLOW
8.6.1 CLOUD BASED SOLUTIONS
8.6.2 ON-PREMISE SOLUTIONS
8.6.3 WEB BASED SOLUTIONS
8.7 LUNG NODULE COMPUTER AIDED DETECTION
8.7.1 ON-PREMISE SOLUTIONS
8.7.2 CLOUD BASED SOLUTIONS
8.7.3 WEB BASED SOLUTIONS
8.8 PATHOLOGY AND CANCER STAGING
8.8.1 CLOUD BASED SOLUTIONS
8.8.2 ON-PREMISE SOLUTIONS
8.8.3 WEB BASED SOLUTIONS
8.9 STATISTICAL AUDIT REPORTING
8.9.1 CLOUD BASED SOLUTIONS
8.9.2 ON-PREMISE SOLUTIONS
8.9.3 WEB BASED SOLUTIONS
8.1 SCREENING PACS
8.10.1 CLOUD BASED SOLUTIONS
8.10.2 ON-PREMISE SOLUTIONS
8.10.3 WEB BASED SOLUTIONS
8.11 PRACTICE MANAGEMENT
8.11.1 CLOUD BASED SOLUTIONS
8.11.2 ON-PREMISE SOLUTIONS
8.11.3 WEB BASED SOLUTIONS
8.12 AUDIT LOG TRACKING
8.12.1 CLOUD BASED SOLUTIONS
8.12.2 ON-PREMISE SOLUTIONS
8.12.3 WEB BASED SOLUTIONS
9 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE
9.1 OVERVIEW
9.2 COMPUTER-ASSISTED SCREENING
9.2.1 CLOUD BASED SOLUTIONS
9.2.2 ON-PREMISE SOLUTIONS
9.2.3 WEB BASED SOLUTIONS
9.3 TRADITIONAL SCREENING
9.3.1 CLOUD BASED SOLUTIONS
9.3.2 ON-PREMISE SOLUTIONS
9.3.3 WEB BASED SOLUTIONS
10 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 NON-SMALL CELL LUNG CANCER (NSCLC)
10.2.1 CLOUD BASED SOLUTIONS
10.2.2 ON-PREMISE SOLUTIONS
10.2.3 WEB BASED SOLUTIONS
10.3 SMALL CELL LUNG CANCER (SCLC)
10.3.1 CLOUD BASED SOLUTIONS
10.3.2 ON-PREMISE SOLUTIONS
10.3.3 WEB BASED SOLUTIONS
11 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM
11.1 OVERVIEW
11.2 STANDALONE
11.2.1 CLOUD BASED SOLUTIONS
11.2.2 ON-PREMISE SOLUTIONS
11.2.3 WEB BASED SOLUTIONS
11.3 INTEGRATED
11.3.1 CLOUD BASED SOLUTIONS
11.3.2 ON-PREMISE SOLUTIONS
11.3.3 WEB BASED SOLUTIONS
12 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE
12.1 OVERVIEW
12.2 INSTITUTIONAL
12.3 INDIVIDUAL
13 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER
13.1 OVERVIEW
13.2 ONCOLOGY CENTERS
13.3 HOSPITALS
13.4 AMBULATORY SURGICAL CENTERS
13.5 OTHERS
14 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDERS
14.3 THIRD PARTY DISTRIBUTOR
15 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION
15.1 MIDDLE EAST & AFRICA
15.1.1 SOUTH AFRICA
15.1.2 SOUTH AFRICA
15.1.3 U.A.E
15.1.4 ISRAEL
15.1.5 EGYPT
15.1.6 REST OF MIDDLE EAST AND AFRICA
16 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 KONINKLIJKE PHILIPS N.V
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 SIEMENS HEALTHCARE GMBH
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 NUANCE COMMUNICATIONS, INC.
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 GENRAL ELECTRIC (GE HEALTHCARE)
18.4.1 COMPANY SNAPSHOT
18.4.2 COMPANY SHARE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENTS
18.5 ONCOCYTE CORPORATION
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENT
18.6 AIDENCE.COM
18.6.1 COMPANY SNAPSHOT
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENT
18.7 ASTRAZENECA
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENT
18.8 CANON MEDICAL INFORMATICS, INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 CORELINE SOFT, CO., LTD.
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENTS
18.1 EON
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 EPIC SYSTEMS CORPORATION
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENT
18.12 F. HOFFMANN-LA ROCHE LTD
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENTS
18.13 FUJIFILM HOLDINGS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 GENESYSTEM
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 HEALTHMYNE
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENTS
18.16 LUNGVIEW
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 MAGVIEW
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENT
18.18 MEDIAN TECHNOLOGIES
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
18.19 MEDTRONIC
18.19.1 COMPANY SNAPSHOT
18.19.2 REVENUE ANALYSIS
18.19.3 PRODUCT PORTFOLIO
18.19.4 RECENT DEVELOPMENTS
18.2 MEVIS MEDICAL SOLUTIONS AG
18.20.1 COMPANY SNAPSHOT
18.20.2 REVENUE ANALYSIS
18.20.3 PRODUCT PORTFOLIO
18.20.4 RECENT DEVELOPMENT
18.21 MYCAREWARE INC.
18.21.1 COMPANY SNAPSHOT
18.21.2 PRODUCT PORTFOLIO
18.21.3 RECENT DEVELOPMENT
18.22 OPTELLUM LTD
18.22.1 COMPANY SNAPSHOT
18.22.2 PRODUCT PORTFOLIO
18.22.3 RECENT DEVELOPMENTS
18.23 PENRAD TECHNOLOGIES INC.
18.23.1 COMPANY SNAPSHOT
18.23.2 PRODUCT PORTFOLIO
18.23.3 RECENT DEVELOPMENT
18.24 REVEALDX
18.24.1 COMPANY SNAPSHOT
18.24.2 PRODUCT PORTFOLIO
18.24.3 RECENT DEVELOPMENT
18.25 THYNK HEALTH
18.25.1 COMPANY SNAPSHOT
18.25.2 PRODUCT PORTFOLIO
18.25.3 RECENT DEVELOPMENT
18.26 VOLPARA SOLUTIONS LIMITED
18.26.1 COMPANY SNAPSHOT
18.26.2 REVENUE ANALYSIS
18.26.3 PRODUCT PORTFOLIO
18.26.4 RECENT DEVELOPMENTS
19 QUESTIONNAIRE
20 RELATED REPORTS
Liste des tableaux
TABLE 1 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 2 MIDDLE EAST & AFRICA CLOUD BASED SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 3 MIDDLE EAST & AFRICA ON-PREMISE SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 4 MIDDLE EAST & AFRICA WEB BASED SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 5 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 6 MIDDLE EAST & AFRICA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 7 MIDDLE EAST & AFRICA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 8 MIDDLE EAST & AFRICA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 9 MIDDLE EAST & AFRICA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 10 MIDDLE EAST & AFRICA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 11 MIDDLE EAST & AFRICA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 12 MIDDLE EAST & AFRICA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 13 MIDDLE EAST & AFRICA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 14 MIDDLE EAST & AFRICA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 15 MIDDLE EAST & AFRICA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 16 MIDDLE EAST & AFRICA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 17 MIDDLE EAST & AFRICA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 18 MIDDLE EAST & AFRICA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 19 MIDDLE EAST & AFRICA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 20 MIDDLE EAST & AFRICA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 21 MIDDLE EAST & AFRICA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 22 MIDDLE EAST & AFRICA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 23 MIDDLE EAST & AFRICA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 24 MIDDLE EAST & AFRICA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 25 MIDDLE EAST & AFRICA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 26 MIDDLE EAST & AFRICA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 27 MIDDLE EAST & AFRICA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 28 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 29 MIDDLE EAST & AFRICA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 30 MIDDLE EAST & AFRICA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 31 MIDDLE EAST & AFRICA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 32 MIDDLE EAST & AFRICA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 33 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 34 MIDDLE EAST & AFRICA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 35 MIDDLE EAST & AFRICA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 36 MIDDLE EAST & AFRICA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 37 MIDDLE EAST & AFRICA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 38 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 39 MIDDLE EAST & AFRICA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 40 MIDDLE EAST & AFRICA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 41 MIDDLE EAST & AFRICA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 42 MIDDLE EAST & AFRICA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 43 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 44 MIDDLE EAST & AFRICA INSTITUTIONAL IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 45 MIDDLE EAST & AFRICA INDIVIDUAL IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 46 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 47 MIDDLE EAST & AFRICA ONCOLOGY CENTERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 48 MIDDLE EAST & AFRICA HOSPITALS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 49 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 50 MIDDLE EAST & AFRICA OTHERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 51 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 52 MIDDLE EAST & AFRICA DIRECT TENDERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 53 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTOR IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 54 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)
TABLE 55 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 56 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 57 MIDDLE EAST & AFRICA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 58 MIDDLE EAST & AFRICA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 59 MIDDLE EAST & AFRICA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 60 MIDDLE EAST & AFRICA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 61 MIDDLE EAST & AFRICA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 62 MIDDLE EAST & AFRICA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 63 MIDDLE EAST & AFRICA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 64 MIDDLE EAST & AFRICA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 65 MIDDLE EAST & AFRICA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 66 MIDDLE EAST & AFRICA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 67 MIDDLE EAST & AFRICA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 68 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 69 MIDDLE EAST & AFRICA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 70 MIDDLE EAST & AFRICA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 71 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 72 MIDDLE EAST & AFRICA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
TABLE 73 MIDDLE EAST & AFRICA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 74 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 75 MIDDLE EAST & AFRICA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 76 MIDDLE EAST & AFRICA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 77 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 78 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 79 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 80 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 81 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 82 SAUDI ARABIA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 83 SAUDI ARABIA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 84 SAUDI ARABIA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 85 SAUDI ARABIA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 86 SAUDI ARABIA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 87 SAUDI ARABIA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 88 SAUDI ARABIA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 89 SAUDI ARABIA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 90 SAUDI ARABIA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 91 SAUDI ARABIA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 92 SAUDI ARABIA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 93 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 94 SAUDI ARABIA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 95 SAUDI ARABIA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 96 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 97 SAUDI ARABIA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
TABLE 98 SAUDI ARABIA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 99 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 100 SAUDI ARABIA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 101 SAUDI ARABIA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 102 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 103 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 104 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 105 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 106 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 107 SOUTH AFRICA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 108 SOUTH AFRICA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 109 SOUTH AFRICA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 110 SOUTH AFRICA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 111 SOUTH AFRICA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 112 SOUTH AFRICA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 113 SOUTH AFRICA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 114 SOUTH AFRICA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 115 SOUTH AFRICA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 116 SOUTH AFRICA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 117 SOUTH AFRICA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 118 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 119 SOUTH AFRICA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 120 SOUTH AFRICA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 121 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 122 SOUTH AFRICA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
TABLE 123 SOUTH AFRICA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 124 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 125 SOUTH AFRICA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 126 SOUTH AFRICA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 127 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 128 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 129 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 130 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 131 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 132 U.A.E LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 133 U.A.E LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 134 U.A.E NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 135 U.A.E DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 136 U.A.E PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 137 U.A.E LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 138 U.A.E PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 139 U.A.E STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 140 U.A.E SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 141 U.A.E PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 142 U.A.E AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 143 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 144 U.A.E COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 145 U.A.E TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 146 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 147 U.A.E NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
TABLE 148 U.A.E SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 149 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 150 U.A.E STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 151 U.A.E INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 152 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 153 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 154 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 155 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 156 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 157 ISRAEL LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 158 ISRAEL LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 159 ISRAEL NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 160 ISRAEL DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 161 ISRAEL PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 162 ISRAEL LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 163 ISRAEL PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 164 ISRAEL STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 165 ISRAEL SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 166 ISRAEL PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 167 ISRAEL AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 168 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 169 ISRAEL COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 170 ISRAEL TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 171 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 172 ISRAEL NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
TABLE 173 ISRAEL SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 174 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 175 ISRAEL STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 176 ISRAEL INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 177 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 178 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 179 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 180 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 181 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 182 EGYPT LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 183 EGYPT LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 184 EGYPT NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 185 EGYPT DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 186 EGYPT PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 187 EGYPT LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 188 EGYPT PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 189 EGYPT STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 190 EGYPT SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 191 EGYPT PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 192 EGYPT AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 193 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 194 EGYPT COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 195 EGYPT TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 196 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 197 EGYPT NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
TABLE 198 EGYPT SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 199 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 200 EGYPT STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 201 EGYPT INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 202 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 203 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 204 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 205 REST OF MIDDLE EAST AND AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
Liste des figures
FIGURE 1 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: SEGMENTATION
FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 11 RISING LUNG CANCER SCREENING PROGRAMS IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 CLOUD BASED SOLUTIONS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET
FIGURE 14 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY MODE OF DELIVERY, 2021
FIGURE 15 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY PRODUCT, 2021
FIGURE 16 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: TYPE, 2021
FIGURE 17 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY APPLICATION, 2021
FIGURE 18 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY PLATFORM, 2021
FIGURE 19 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY PURCHASE MODE, 2021
FIGURE 20 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY END USER, 2021
FIGURE 21 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 22 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: SNAPSHOT (2021)
FIGURE 23 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2021)
FIGURE 24 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2022 & 2029)
FIGURE 25 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2021 & 2029)
FIGURE 26 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY MODE OF DELIVERY (2022-2029)
FIGURE 27 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY SHARE 2021 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
